Industry Updates
Press Releases
QT Ultrasound to Bring Breast Imaging Innovation to Asia Through Joint Venture with TCL Healthcare Equipment
QT Ultrasound®, developer of the QTscan®, will bring its radiation- and compression-free 3D breast imaging technology to China, and other Asian markets, through a partnership...
Press Releases
Eisai to Take over Manufacturing and Marketing Approval for Equfina 50mg Tablets in Japan
Eisai Co., Ltd. announced that it will take over by transfer the manufacturing and marketing approval of Parkinson's disease treatment Equfina 50mg TABLETS (safinamide mesilate,...
Press Releases
Lumenis Announces NuEra Tight with FocalRF Technology, a Breakthrough in Aesthetic Medical Devices, now available in Europe and the Middle East
Lumenis Ltd., the world's largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, is proud to announce the revolutionary NuEra Tight with FocalRF...
Press Releases
Nocca Robotics launches High-Flow Oxygen Therapy Device Noccarc H210 for critical care treatment of COVID-19 patients
The newly launched device is driven by novel technology and helps patients with respiratory issues breathe comfortably through nasal cannN Noccarobotics, High-Flow Oxygen Therapy Device,...
Press Releases
NextGen Healthcare Unveils Latest Behavioral Health Suite
NextGen Healthcare, Inc., a leading provider of ambulatory-focused technology solutions, announced the availability of the next generation of its behavioral health suite. Building upon an...
Press Releases
Australian health tech company Alcidion launches ‘smart clinical asset’ in the UK
Australian health tech company Alcidion has launched a ‘smart clinical assest’ in the UK which it hopes will help the NHS.
Miya Precision integrates information from...
Press Releases
Abbott’s once-a-day Ivabradine receives DCGI approval for heart failure and angina patients
The global healthcare company Abbott recently announced that it has received approval from the Drugs Controller General of India (DCGI) for its Ivabradine, once-a-day formulation...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
